Clinical Trial Update: Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency [NA]

View source ↗

Summary

A randomized trial of polyethylene-glycol-conjugated interleukin-2 for Common Variable Immunodeficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Variable Immunodeficiency

Drugs mentioned

• Polyethylene-Glycol-Conjugated Interleukin 2 (polyethylene glycol-conjugated interleukin-2)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Common Variable Immunodeficiency | NA | Status: COMPLETED